Gordie's Midday Gossip - New Weight Loss Drug

New Weight Loss Study Finds Zepbound Outperforms Ozempic & Wegovy

JESSE JONES: People with diabetes struggle to find Ozempic as more doctors prescribe it for weight loss

By Gordie Daniels

A new weight loss study has found that drug brands Zepbound and Mounjaro led to more weight loss compared to Ozempic and Wegovy. The active ingredient in Zepbound and Mounjaro is tirzepatide, while the active ingredient in Ozempic and Wegovy is semaglutide. This new study published by JAMA Internal Medicine found patients taking the highest Zepbound dose lost about 21% of their body weight during a 72-week period. Meanwhile, patients on the highest dose of Wegovy lost around 15% of their body weight during a 68-week period.

0
Comments on this article
0
On Air101.5 The Vibe - Tampa Bay’s only R&B Logo
    View All
    1-877-999-1015

    mobile apps

    Everything you love about 1015vibe.com and more! Tap on any of the buttons below to download our app.

    Base64 encoded image Base64 encoded image

    smart speakers

    Ask your smart speaker to play 101.5 The Vibe.